LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel GlobeNewswire January 21, 2026 NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced the appointment Dr. Minako Pazdera as […]